top of page

Menopause

shutterstock_1549485035.jpg

The healthyher.life team supports a holistic approach to managing women’s hormonal healthcare. Our goal is to help our members be well-informed about their hormonal health, by providing them with evidence-based integrated health information that includes the current standard of medical care advised by qualified physicians, clinical insights from licensed allied health professionals (naturopathic doctors, nurse-practitioners, nutritionists, psychotherapists) and new health innovations that will be soon coming to market. Always consult with your doctor regarding your medical condition, diagnosis, treatment, or to seek personalized medical advice. 

Introduction to Menopause
 

Reviewed by Rina Carlini, PhD and Joanne Tejeda, PhD
 

What is menopause? 

 

Menopause is a natural biological process that occurs to all individuals with female reproductive anatomy and begins between ages 45-55. Menopause is clinically determined  12 months after the last menstrual cycle, when hormonal levels of estrogen and progestin decline, leading to changes in ovarian function that result in termination of menstruation since the ovary no longer produces eggs.

​

Menopause is categorized in 3 stages: 

  • Stage 1 - Perimenopause: a transition period associated with the onset of hormonal changes and symptoms which usually lasts from a few months up to 4 years.

  • Stage 2 - Menopause: period of 12 consecutive months with no menstrual cycle.

  • Stage 3 - Post-menopause: at this point, the symptoms start to subdue and get milder and may even disappear.

 

Menopause is not considered a disease; however, many health conditions arise as a result of the hormonal changes during menopause, these include: 

  • Cardiovascular disease

  • Osteoporosis

  • Type II diabetes

  • Colorectal cancer

 

Sometimes surgery (as in the case of hysterectomy) can trigger menopause to begin early in which case it is called premature menopause.

​

Symptoms

There may be a variation between the symptoms experienced by individuals: 

  • Vasomotor symptoms such as hot flashes (most reported symptom)

  • Irregular menstrual cycles

  • Vaginal dryness

  • Pain during intercourse

  • Trouble sleeping

  • Moodiness and irritability

  • Depression

  • Weight gain

  • Thinning of the hair or hair loss

 

Treatment Options

Symptom management for menopause includes both drug and non-drug options such as: 

 

Hormone therapies:

 

Non-hormonal therapies:

  • Low-dose paroxetine

  • Gabapentin

  • Venlafaxine

 

Drug-free treatments:

  • Physiotherapy and/or behavioural therapy, massage therapy

  • Exercise and nutrition management

  • Non-prescription water-based lubricant and moisturizers

  • Meditation, relaxation therapy

  • Naturopathy, homeopathy

  • Acupuncture

  • Herbal remedies

 

The transition through all stages of menopause occurs very slowly, lasting up to 8 years, and in some cases, symptoms can last up to 10 years after menopause. Menopause is a natural and inevitable progression of physically getting older. 

​

Tags

Menopause, perimenopause, post-menopause, vasomotor symptoms, hot flashes, therapy, drug, drug-free therapy, hormonal health, women’s health

 

​

​

References 

To view the list of references, click on the plus symbol 

Uterine Fibroids

What are Uterine Fibroids?  

By Henry Xu PhD., Joanne Tejeda, PhD.
July 12, 2024

KC Cover Photo - Fibroids.png

Uterine fibroids, also known as leiomyomas or myomas, are non-cancerous growths in the uterus composed of muscle and fibrous tissue. They can range in size from a pea to as large as a melon. 

Globally, there are 226 million cases of uterine fibroids, with the highest prevalence among women aged 40-50. About 80% of women will develop uterine fibroids in their lifetime.

 

In the United States, about 26 million women aged 15 to 50 that are diagnosed with fibroids [1]. By age 50, nearly 80% of Black women and 70% of white women will develop fibroids.  While experiences vary, about 25% of women with fibroids suffer from severe symptoms requiring treatment [2].  

 

What Causes Uterine Fibroids?  

The exact cause of uterine fibroids is not fully understood, but several factors are believed to contribute to their development, these include [3]: 

​

1. Hormones that regulate the menstrual cycle, estrogen and progesterone, promote the growth of fibroids. When hormone levels drop after menopause, fibroid growth tends to decrease [4]. 

 

2. Evidence suggests that family genetics is a contributing factor as uterine fibroids tend to occur within the family [5]. 

 

3. Race is a key factor for uterine fibroids, as African-American women are 3-times more likely to develop fibroids and at a younger age compared to women of other racial groups [6]. 

 

4. Obesity has been linked to an increase in the risk of fibroids [7]. 

 

5. Vitamin D deficiency is also associated with increased risk of uterine fibroids [8]. 

 

6. Women with high blood pressure typically have a significantly higher risk of developing uterine fibroids [5]. 

 

Symptoms of Uterine Fibroids [2]: 

  • Heavy menstrual bleeding 

  • Prolonged periods (lasting more than a week) 

  • Iron Deficiency Anemia 

  • Pelvic pain or pressure 

  • Frequent urination 

  • Difficulty emptying the bladder 

  • Constipation 

  • Backache  

  • Leg pains 

  • Reproductive issues, such as infertility or pregnancy complications 

 

Diagnosis of Uterine Fibroids: 

Diagnosis typically begins with taking the patient’s history and identifying symptoms related to uterine fibroids. A pelvic exam is then conducted to check for irregularities in the shape and size of the uterus. In certain cases, blood tests may be conducted to rule out other causes of symptoms, like anemia from heavy bleeding. 

​

Imaging tests are crucial for an accurate diagnosis. Ultrasound is the primary imaging technique used due to its ability to visualize fibroids and assess their size, number, and location. Saline infusion, involving the injection of a salt solution into the uterus, is often used to create clearer ultrasound images [9].   

​

Magnetic resonance imaging (MRI) is another valuable tool, especially for detailed mapping of fibroids, which is essential for treatment planning. MRI also helps distinguish fibroids from other pelvic conditions. Other traditional imaging techniques include hysteroscopy, which allows direct visualization of the uterine cavity using a thin, lighted scope, aiding in the identification of fibroids. [10]. 

 

Treatments of Uterine Fibroids: 

​Medications ​

For mild symptoms, over-the-counter pain relief can be used. Hormonal treatments, such as oral contraceptives or special injections that lower hormone levels, can also help shrink fibroids [4]. 

 

Non-Invasive Procedures â€‹

Radiofrequency ablation is a procedure that uses radio energy and heat to remove uterine fibroids. It is performed with a small, energized probe that is passed through the vagina and cervix into the uterus, guided by ultrasound throughout the procedure [11]. 

​​

Minimally Invasive Procedures ​

Uterine artery embolization (UAE) is a treatment in which surgeons inject small particles into the arteries surrounding the fibroid to cut off its blood flow, causing it to shrink [12]. 

Radiofrequency ablation can also be used in minimally invasive procedures, where laparoscopic scopes are inserted into small incisions to guide the procedure [13].  

​

Traditional Surgical Procedures ​

An abdominal myomectomy involves making an incision in the abdominal wall to access the uterus and surgically remove fibroids from its surface.  

For women with severe symptoms who do not plan on having more children in the future, hysterectomy is used as a last resort [14]. 

​

Treatment of uterine fibroids can be time-consuming. Many women often go through multiple doctor visits before being diagnosed, and up to 32% of diagnosed women wait more than 5 years before seeking treatment [2]. Improved access to educational resources is needed to help guide women in their journey when seeking treatment for uterine fibroids. 

 

New Medical Innovations ​

Medical device innovators are constantly developing new treatment tools for the non-invasive removal of uterine fibroids. Radiologist Dr. Elizabeth David at Sunnybrook Health Sciences Centre in Toronto is working on shrinking fibroids using high-intensity focused ultrasound guided by MRI. She recently completed a clinical trial in which 90% of patients reported being symptom-free after the procedure. [15]. 

 

Helpful Resources: 

Living with fibroids can be challenging, with women reporting an average loss of 5.1 work hours per week due to the condition [1].  

​

The Uterine Fibroids Toolkit: A Patient Empowerment Guide by the Society for Women's Health Research is a fantastic resource, offering information to help you understand your condition and make informed decisions. 

​

Join the Healthyher.Life community to connect with others who have had similar experiences with fibroids. 

References: 

[1] Lou, Zheng et al. “Global, regional, and national time trends in incidence, prevalence, years lived with disability for uterine fibroids, 1990-2019: an age-period-cohort analysis for the global burden of disease 2019 study.” BMC public health vol. 23,1 916. 19 May. 2023, doi:10.1186/s12889-023-15765-x 

[2] Society for Women's Health Research. *Uterine Fibroids Toolkit: A Patient Empowerment Guide*. Society for Women's Health Research, 2023. 

[3] Stewart, E A. “Uterine fibroids.” Lancet (London, England) vol. 357,9252 (2001): 293-8. doi:10.1016/S0140-6736(00)03622-9 

[4] Bulun, Serdar E. “Uterine fibroids.” The New England journal of medicine vol. 369,14 (2013): 1344-55. doi:10.1056/NEJMra1209993 

[4] American College of Obstetricians and Gynecologists. “Management of Symptomatic Uterine Leiomyomas.” ACOG Practice Bulletin No. 228, July 2021. 

[5] Stewart, E A et al. “Epidemiology of uterine fibroids: a systematic review.” BJOG : an international journal of obstetrics and gynaecology vol. 124,10 (2017): 1501-1512. doi:10.1111/1471-0528.14640 

[6] Eltoukhi, Heba M et al. “The health disparities of uterine fibroid tumors for African American women: a public health issue.” American journal of obstetrics and gynecology vol. 210,3 (2014): 194-9. doi:10.1016/j.ajog.2013.08.008 

[7] Pavone, Dora et al. “Epidemiology and Risk Factors of Uterine Fibroids.” Best practice & research. Clinical obstetrics & gynaecology vol. 46 (2018): 3-11. doi:10.1016/j.bpobgyn.2017.09.004 

[8] Baird, Donna Day et al. “Vitamin d and the risk of uterine fibroids.” Epidemiology (Cambridge, Mass.) vol. 24,3 (2013): 447-53. doi:10.1097/EDE.0b013e31828acca0 

[9] Palheta, Michel Santos et al. “Reporting of uterine fibroids on ultrasound examinations: an illustrated report template focused on surgical planning.” Radiologia brasileira vol. 56,2 (2023): 86-94. doi:10.1590/0100-3984.2022.0048 

[10] De La Cruz, Maria Syl D, and Edward M Buchanan. “Uterine Fibroids: Diagnosis and Treatment.” American family physician vol. 95,2 (2017): 100-107. 

[11] Christoffel, Ladina et al. “Transcervical Radiofrequency Ablation of Uterine Fibroids Global Registry (SAGE): Study Protocol and Preliminary Results.” Medical devices (Auckland, N.Z.) vol. 14 77-84. 3 Mar. 2021, doi:10.2147/MDER.S301166 

[12] Gupta, Janesh K et al. “Uterine artery embolization for symptomatic uterine fibroids.” The Cochrane database of systematic reviews ,5 CD005073. 16 May. 2012, doi:10.1002/14651858.CD005073.pub3 

[13] Milic, Andrea et al. “Laparoscopic ultrasound-guided radiofrequency ablation of uterine fibroids.” Cardiovascular and interventional radiology vol. 29,4 (2006): 694-8. doi:10.1007/s00270-005-0045-9 

[14] Guarnaccia, M M, and M S Rein. “Traditional surgical approaches to uterine fibroids: abdominal myomectomy and hysterectomy.” Clinical obstetrics and gynecology vol. 44,2 (2001): 385-400. doi:10.1097/00003081-200106000-00024 

[15] Single Arm Study Using the Symphony -- MRI Guided Focused Ultrasound System for the Treatment of Leiomyomas (HIFUSB). ClinicalTrials.gov identifier: NCT03323905. Updated July 9, 2024. Accessed July11, 2024 https://clinicaltrials.gov/study/NCT03323905 

Iron Deficiency

The Hidden Struggles: Iron Deficiency and Anemia in Women

By Henry Xu, Ph.D,  Joanne Tejeda, Ph.D
July 2, 2024

Anemia Cover Photo.png

Iron is an essential mineral for your body, playing crucial roles in your immune and cardiovascular systems. It is mainly used to produce a protein called hemoglobin, which carries oxygen in red blood cells. When your body lacks sufficient iron, it can result in iron deficiency anemia, a common health issue affecting many women worldwide. Globally, more than 33% of women aged 15-49 suffer from anemia, with over 800 million cases due to iron deficiency – twice as many compared to men [1]. In Canada, an estimated 29% of women aged 19-50 experience iron deficiency anemia.  [2]. These conditions can lead to various health complications, impacting overall quality of life and productivity.  

​

In this article, we explore how to identify iron deficiency anemia and manage iron levels. Catching symptoms of anemia early and taking steps to maintain healthy iron levels are crucial for women's health. 

​

What Causes Iron Deficiency Anemia in Women?  

Iron deficiency is a condition where the body does not have enough iron to produce hemoglobin. When this condition worsens and there isn’t enough oxygen in red blood cells, it can result in iron deficiency anemia, potentially leading to tissue and organ damage. [3]. Several factors contribute to the increased prevalence of iron deficiency in women. Women of reproductive age are particularly susceptible to iron deficiency due to blood loss during menstruation [4]. 

​

Abnormal uterine bleeding (AUB) – where bleeding from the uterus is abnormal – affects up to 25% of women of reproductive age. The most common subtype of AUB is heavy menstrual bleeding (menorrhagia), which significantly increases iron loss [5]. An ongoing comprehensive review by Dr. Michelle Zeller from McMaster University is examining the effectiveness of iron treatments for AUB [6]. This research aims to improve our understanding of how iron treatments can enhance health outcomes for women with iron deficiency due to AUB. 

​

Iron deficiency is also a common issue for expecting and postpartum mothers. The increased iron demands during pregnancy and lactation can lead to the rapid depletion of iron stores in the mother’s body, especially if the pregnancy is not supported with additional iron through nutrients or supplements. 

​

An unbalanced diet with limited consumption of iron-rich foods, such as red meat, poultry, and fish, is another common factor leading to iron deficiency. Vegetarian and vegan diets may also pose a risk if not carefully managed to include alternative iron sources. In addition, several gastrointestinal conditions, such as celiac disease, Crohn's disease, inflammatory bowel disease (IBS), and those who have undergone gastric bypass surgery, can decrease iron absorption, leading to iron deficiency. 

 

Common Symptoms of Iron Deficiency Anemia 

The symptoms of iron deficiency and iron deficiency anemia can vary in severity and may include [4, 7]: 

Iron Deficiency symptoms (1080x1080) (1).png

The Impact of Iron Deficiency Anemia on Women’s Health 

​

Adolescent Women

During these developmental years, bodies are rapidly changing and growing, making iron even more important. Without enough iron, adolescents can feel tired, weak, and have trouble concentrating, impacting their performance and daily activities. Additionally, as girls begin menstruating, they lose iron each month, increasing their risk of deficiency. Ensuring sufficient iron is essential for maintaining their energy levels, supporting growth, and promoting overall well-being [8]. 

​

Adult Women 

Iron is equally important for adult women. Without healthy levels of iron, they might feel tired, weak, or even dizzy, greatly impacting their work and social life. Women periodically lose iron during menstruation, making it even harder to meet the body’s iron needs. Heavy and prolonged athletic activities also increase iron loss through sweating [4]. 

 

Pregnant Women 

Iron needs increase significantly to support fetal development and increased blood volume. Pregnant women are often advised to take prenatal vitamins that include iron to prevent deficiency. Monitoring iron levels throughout pregnancy is essential to ensure both maternal and fetal health. Iron-deficient mothers can encounter complications during pregnancy, including preterm delivery and low birth weight [4]. 

 

Perimenopausal Women 

During perimenopause, women may experience irregular or increased menstrual volume. These changes can contribute to increased iron loss and result in iron deficiency anemia. Some symptoms of perimenopause, such as fatigue and headaches, might overlap with iron deficiency symptoms, making it important for perimenopausal women to regularly check their blood iron levels to avoid developing anemia [4]. 

 

Postmenopausal Women 

Postmenopausal women generally have a lower risk of iron deficiency due to the cessation of menstrual blood loss. However, they can still be affected by insufficient dietary iron or gastrointestinal issues. Regular health check-ups and maintaining a balanced diet are important for preventing iron deficiency in this age group [4]. 

 

How is Iron Deficiency Anemia Diagnosed? 

Diagnosing iron deficiency anemia involves a combination of clinical evaluation and laboratory tests [3], including:  

​

1. A Complete Blood Count (CBC), which is a comprehensive blood test used to evaluate overall health and detect a variety of disorders, including anemia, infection, and many other diseases. The CBC measures several components and features of your blood, such as Red Blood Cells (RBCs), White Blood Cells (WBC), Hemoglobin (Hgb), Hematocrit (Hct), and Platelets.

​

2. A Serum Ferritin Test that measures the level of ferritin in your blood. Ferritin is a protein that stores iron in your body's cells, and the amount of ferritin in your blood reflects the amount of stored iron. This test helps to evaluate your body's iron levels and diagnose conditions related to iron deficiency or excess. Low ferritin levels indicate low iron stores, which can lead to iron deficiency anemia.​​​

Interpretation of Serum Ferritin Test Results 

Serum Ferrintin Table.jpg

3. A Serum Iron and Total Iron-Binding Capacity (TIBC) test that measures the amount of circulating iron and the blood’s capacity to bind iron, respectively. Low serum iron and high TIBC levels are indicative of iron deficiency. 

​

4. The Transferrin Saturation Test used to evaluate how much iron is bound to transferrin, the protein that transports iron in the blood. Low transferrin saturation indicates insufficient iron supply. 

 

​

Treatment and Prevention 

The primary goals in treating iron deficiency anemia are to replenish iron stores and address any underlying causes [3,4]. Dietary changes are usually a fundamental step in treatment and prevention. Heme iron, found in animal products, is more readily absorbed by the body compared to non-heme iron in plant-based foods. Including vitamin C-rich foods in meals can enhance non-heme iron absorption. 

 

​For women with dietary restrictions or needing additional iron, ferrous sulfate and other oral supplements are commonly used to treat iron deficiency. While effective, these supplements can cause gastrointestinal side effects like constipation and nausea, which can be mitigated by taking them with meals and consuming fiber. For those who cannot tolerate oral iron or have severe deficiencies, intravenous iron infusions may be necessary, especially in cases of absorption issues. Always consult your doctor to determine which supplement option is best for you. 

 

If you're persistently tired or noticing other symptoms, consult a healthcare professional about iron deficiency anemia. Proactive steps like eating a balanced diet and getting regular check-ups can help maintain healthy iron levels and ensure your well-being. 

 

Wondering if You Have Unmet Iron Needs? 

Join us on July 24th, 2024, for Healthyher.Life's Women Talking™ Wednesday virtual event: "Iron is Essential for Your Health and Vitality – Are You Getting Enough?" featuring Dr. Michelle Zeller, clinical hematologist and Associate Professor at McMaster University. 

WTW-July 2024-Zeller (1).png

References: 

[1] GBD 2021 Anaemia Collaborators. “Prevalence, years lived with disability, and trends in anaemia burden by severity and cause, 1990-2021: findings from the Global Burden of Disease Study 2021.” The Lancet. Haematology vol. 10,9 (2023): e713-e734. doi:10.1016/S2352-3026(23)00160-6 

[2] Cooper, M., Bertinato, J., Ennis, J. K., Sadeghpour, A., Weiler, H. A., Dorais, V.. “Population Iron Status in Canada: Results from the Canadian Health Measures Survey 2012-2019.” The Journal of Nutrition, Mar 2023, Volume 153:5, pp1534-1543. doi:10.1016/j.tjnut.2023.03.012 

[3] Kumar, A., Sharma, E., Marley, A., Samaan, M. A., & Brookes, M. J., “Iron deficiency anaemia: pathophysiology, assessment, practical management.” BMJ open gastroenterology, 2022, Volume 9:1:e00759, doi: 10.1136/bmjgast-2021-000759 

[4] Percy, L., Mansour, D., Fraser, I. “Iron deficiency and iron deficiency anaemia in women.” Best Practice & Research Clinical Obstetrics & Gynaecology, 2017, Volume 40, pp 55-67, doi: 10.1016/j.bpobgyn.2016.09.007 

[5] Whitaker, Lucy, and Hilary O D Critchley. “Abnormal uterine bleeding.” Best practice & research. Clinical obstetrics & gynaecology vol. 34 (2016): 54-65. doi:10.1016/j.bpobgyn.2015.11.012 

[6] Nazaryan, H., Watson, M., Ellingham, D., Thakar, S., Wang, A., Pai, M., Liu, Y., Rochwerg, B., Gabarin, N., Arnold, D., Sirotich, E., Zeller, M. P. “Impact of iron supplementation on patient outcomes for women with abnormal uterine bleeding: a protocol for a systematic review and meta-analysis.” Systematic reviews, Jul 2023, Volume 12:1, pp 121, doi: 10.1186/s13643-023-02222-4 

[7] “Iron-Deficiency Anemia.” Office on Women's Health, U.S. Department of Health and Human Services, Feb. 2022, www.womenshealth.gov/a-z-topics/iron-deficiency-anemia

[8] Aksu, Tekin, and Åžule Ünal. “Iron Deficiency Anemia in Infancy, Childhood, and Adolescence.” Turkish archives of pediatrics vol. 58,4 (2023): 358-362. doi:10.5152/TurkArchPediatr.2023.23049 

[9] “Iron-Deficiency Anemia.” National Heart Lung and Blood Institute, U.S. Department of Health and Human Services, 24 Mar. 2022, www.nhlbi.nih.gov/health/anemia/iron-deficiency-anemia

[10] Mei, Zuguo et al. “Physiologically based serum ferritin thresholds for iron deficiency in children and non-pregnant women: a US National Health and Nutrition Examination Surveys (NHANES) serial cross-sectional study.” The Lancet. Haematology vol. 8,8 (2021): e572-e582. doi:10.1016/S2352-3026(21)00168-X 

Association of serum cortisol in women with brain biomarkers of Alzheimer’s risk 

Reviewed by Rina Carlini, PhD
April 22, 2024

brain-health.jpg

Image licensed from Shutterstock #2188096049 

New research insights about menopausal women’s brain health was reported in March 2024 in a neuroscience research study led by Dr. Lisa Mosconi and co-workers of the Weill Cornell Medicine in New York City [1].  The research investigated the sex-specific relationship between serum cortisol levels and brain biomarkers associated with Alzheimer's disease risk. 

​

Alzheimer's disease is a progressive neurodegenerative disorder characterized by cognitive decline and memory loss, with increasing evidence suggesting a link between stress-related hormones such as cortisol and the development of Alzheimer's Disease (AD). However, existing research has largely overlooked potential sex differences in these associations. 

​

To address this gap, Dr. Mosconi and colleagues conducted a study involving 277 participants, to examine the relationship between serum cortisol levels and brain biomarkers of Alzheimer's risk, while considering sex-specific differences. The study included both male and female participants aged 35–65 years who have risk factors for late-onset AD such as a family history and/or the APOE4 genotype, and who were assessed prior to the study of having normal cognitive function. The research methods used advanced neuroimaging techniques to assess various brain biomarkers associated with Alzheimer's disease, such as amyloid-beta deposits and neurodegeneration. 

​

The study revealed sex-specific associations between serum cortisol levels and brain biomarkers of Alzheimer's risk. Specifically, higher levels of serum cortisol were associated with increased amyloid-beta deposits in women but not in men. Amyloid-beta deposition is a hallmark pathological feature of Alzheimer's disease and is believed to contribute to the development and progression of the condition. The research findings suggests that elevated cortisol levels may exacerbate amyloid-beta deposition in women, thereby increasing their risk of developing Alzheimer's disease. 

​

Furthermore, the study found no significant association between serum cortisol levels and neurodegeneration biomarkers in either men or women. Neurodegeneration is another critical aspect of Alzheimer's pathology, and is characterized by the progressive loss of neurons and brain tissue. The lack of association suggests that cortisol may have a more specific effect on amyloid-beta deposition rather than overall neurodegeneration, in the context of Alzheimer's disease risk. 

​

The researchers did not observe reduced cognitive performance in women compared to men, nor did their study confirm the findings of a previous research study in 2018 that reported a stronger association of cortisol with memory in women compared to age-controlled men [2]. It was recommended that to advance this research, a broad range of cognitive tests might be needed to capture the subtle cognitive changes in men and women that are associated with cortisol levels.  

​

In summary, Dr. Mosconi's study sheds light on the sex-specific associations of serum cortisol with brain biomarkers of Alzheimer's risk. The findings underscore the importance of considering sex differences in Alzheimer's research and highlight the potential role of stress-related hormones in the development and progression of the disease. Further research in this area may contribute to the development of personalized strategies and therapeutic interventions for Alzheimer's prevention and treatment. 

References

  1. Mosconi, L., Williams, S., Carlton, C. et al. Sex-specific associations of serum cortisol with brain biomarkers of Alzheimer’s risk. Scientific Reports, volume 14, 5519 (2024). https://doi.org/10.1038/s41598-024-56071-9  

  2. Echouffo-Tcheugui, J. B. et al. Circulating cortisol and cognitive and structural brain measures: The Framingham Heart Study. Neurology 91, e1961–e1970 (2018).  https://doi.org/10.1212/WNL.0000000000006549  

New study suggests that stress, age, BMI and some gastrointestinal factors are associated with severity of menopause symptoms

Reviewed by Rina Carlini, PhD
October 13, 2023

A group of physician researchers from Vilnius University in Lithuania examined whether there was any connection between the gut microbiome and menopause symptoms in women. They launched a study to investigate how gastrointestinal factors, stress, physical activity and other factors may affect the prevalence and intensity of menopause symptoms.

Study Overview

​

A cross-sectional study was conducted to determine if there were any significant correlations between gastrointestinal symptoms and perceived stress levels and menopausal symptoms such as gynecological health, vasomotor symptoms (hot flashes, night sweats), sleep and physical activity in women who were in pre-menopause, peri-menopause and post-menopause reproductive stages. The study enrolled 693 women participants who were approximately between 47-53 years of age, and analyzed their responses using the Perceived Stress Scale (PSS) and Menopause-Specific Quality of Life Questionnaire (MENQOL).

 

Key Findings

​

It was found that age and reproductive stage, perceived stress, body mass index (BMI), physical activity, diagnosis of depression or anxiety disorder, and some gastrointestinal symptoms (such as frequency of defecation, and Bristol stool consistency) had a significant association with the intensity of menopausal symptoms, especially the vasomotor symptoms of hot flashes and night sweats. The study authors reported that further research is needed to confirm the relationship between stress, gastrointestinal, and menopausal symptoms.

​

Reference

Menopause (2023):10.1097/GME.0000000000002259, October 3, 2023. | DOI: 10.1097/GME.0000000000002259

Related Readings

Coming soon

Coming soon

A pragmatic approach to management of menopause

Source: Canadian Medical Association Journal
May 15, 2023

A recent article published by the Canadian Medical Association Journal recommends hormone replacement therapy (also known as HRT) as the first line of treatment for menopause patients who do not have health risk factors. The article also explains other hormonal and non-hormonal solutions to manage menopausal symptoms.

MicrosoftTeams-image (6).png

Coming soon

Coming soon

cmaj picture.png

Hormone therapy should be offered to more women with severe menopause: review

Source: CBC News
May 15, 2023

CBC News recently interviewed Dr. Iliana Lega, an endocrinologist at Women’s College Hospital in Toronto who is the lead author of a new Canadian Medical Association Journal (CMAJ) article entitled: “A pragmatic approach to the management of menopause”, which discusses the benefits and risks of hormone therapy to manage severe menopause symptoms.

Photo Image obtained from CBC News article (sourced by S_L/Shutterstock).

bottom of page